-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Registration of visual impairment due to diabetic retinopathy in a subpopulation of Cambridgeshire
Original Research
(2095) Views (596) Full article downloads
Authors: Patel Gordon-Bennett, Aseema Misra, Wendy Newsom, Declan Flanagan
Published Date September 2008
Volume 2009:3 Pages 75 - 79
DOI: http://dx.doi.org/10.2147/OPTH.S3758
Patel Gordon-Bennett1, Aseema Misra2, Wendy Newsom1, Declan Flanagan2
1Eye Department, Hinchingbrooke Hospital, Hinchingbrooke Park, Huntingdon, Cambridgeshire, UK; 2Eye Department, Addenbrookes Hospital, Hills Road, Cambridge, Cambridgeshire, UK
Background/Aims: The UK National Screening Committee (NSC) has set 18 standards for diabetic retinopathy (DR) screening services in England and Wales, the first of which is to reduce new visual impairment (VI) due to DR by 10% within 5 years. This study examined the incidence of VI due to DR in Cambridgeshire (City, South, and Huntingdonshire) in order to establish a baseline rate of VI registration.
Methods: A retrospective review of all certificates of visual impairment (CVI) for 2004 and 2005 was conducted. Hospital records of patients registered due to DR were reviewed to ascertain conformity to NSC Standards. The incidence of VI registration due to DR was calculated.
Results: The number of registrations predominantly due to DR was 18; 13 visually impaired and 5 with severe VI. The rates of VI and severe VI predominantly due to DR were 17.1 and 6.5 per million per year, respectively. The VI and severe VI registration rates in the diabetic population were 600 and 230 per million per year, respectively.
Conclusion: The severe VI registration rate due to DR lies within the national standard. The VI registration rate exceeds 1990–1991 national standards but lies within 1999–2000 national figures.
Keywords: diabetic retinopathy, visual impairment, severe visual impairment, registration, certification of visual impairment
Readers of this article also read:
International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia




